Prostate Cancer Trial, Recruiting NCT06640959 Sponsor: The Christie NHS Foundation Trust Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06640959
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men aged 18 or older who are able to give their consent to participate
  • People who have recently been diagnosed with prostate cancer that has been confirmed by a tissue sample (biopsy), is contained within or near the prostate (has not spread to lymph nodes or other parts of the body), and is classified as intermediate to high risk
  • People whose planned treatment is a specific type of radiation therapy to the prostate, given as 20 sessions at a particular dose (60Gy over 4 weeks), with the aim of curing the cancer
  • People who are reasonably physically active and able to carry out daily activities, with little to no limitation from their illness (confirm with trial site)

Who may not be able to join:

  • People who have taken antibiotic medicines — by mouth, injection, or drip — within the 2 months before joining the trial
  • People who have received chemotherapy, immunotherapy, or other treatments that suppress or affect the immune system within the 6 months before joining
  • People who have regularly taken high-dose probiotic supplements (at or above a certain level of live bacteria per day) within the 12 months before joining — this includes certain named probiotic products (confirm with trial site for exact products and thresholds)
  • People who have been diagnosed with inflammatory bowel disease (such as Crohn's disease or ulcerative colitis) or coeliac disease
  • People who have previously had bowel (colorectal) cancer
  • People who have had surgery to remove all or most of their large bowel (colon)
  • People who have a history of a condition called diverticulitis (a serious inflammation of the bowel wall) — note that having diverticular disease without past inflammation may still be permitted (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01612008863

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Christie NHS Foundation Trust
Registry
ClinicalTrials.gov
Start date
19 November 2024
Est. completion
1 July 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Feasibility of obtaining longitudinal blood, urine and stool samples

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov